triamcinolone has been researched along with Smoking Cessation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimaki, Y; Kondo, K; Matsushima, K; Nishijima, H; Nito, T; Shand, FH; Tsunoda, K; Ueha, R; Ueha, S; Yamasoba, T | 1 |
Marchand, E | 1 |
1 review(s) available for triamcinolone and Smoking Cessation
Article | Year |
---|---|
[Long-term trials assessing pharmacological treatments in COPD: lessons and limitations].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Budesonide; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluticasone; Humans; Ipratropium; Long-Term Care; Male; Middle Aged; Prednisone; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Scopolamine Derivatives; Smoking Cessation; Tiotropium Bromide; Triamcinolone | 2010 |
1 other study(ies) available for triamcinolone and Smoking Cessation
Article | Year |
---|---|
Laryngeal mucus hypersecretion is exacerbated after smoking cessation and ameliorated by glucocorticoid administration.
Topics: Animals; Cytokines; Disease Models, Animal; Glucocorticoids; Laryngeal Mucosa; Laryngitis; Male; Mucus; Rats, Sprague-Dawley; Smoking; Smoking Cessation; Triamcinolone | 2017 |